Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Nothing Changes

<< Previous

Bullboard Posts

Next >>

Comment by unclejerryon May 21, 2021 9:52am

150 Views

Post# 33247163

RE:RE:Nothing Changes

WakeUPP you are so stupid, you keep using the same nonsense about 10 rats, clearly you have no idea on how companies do studies, just look at how GW Pharma started their initial clinical studies....why are you so dumb and keep posting about something you don't know and a stock you don't own. You'r a pathetic loser and a joke on this forum.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale